Literature DB >> 7688028

Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta.

Y Vodovotz1, C Bogdan, J Paik, Q W Xie, C Nathan.   

Abstract

Activated mouse peritoneal macrophages produce nitric oxide (NO) via a nitric oxide synthase that is inducible by interferon gamma (IFN-gamma): iNOS. We have studied the mechanisms by which transforming growth factor beta 1 (TGF-beta) suppresses IFN-gamma-stimulated NO production. TGF-beta treatment reduced iNOS specific activity and iNOS protein in both cytosolic and particulate fractions as assessed by Western blot with monospecific anti-iNOS immunoglobulin G. TGF-beta reduced iNOS mRNA without affecting the transcription of iNOS by decreasing iNOS mRNA stability. Even after iNOS was already expressed, TGF-beta reduced the amount of iNOS protein. This was due to reduction of iNOS mRNA translation and increased degradation of iNOS protein. The potency of TGF-beta as a deactivator of NO production (50% inhibitory concentration, 5.6 +/- 2 pM) may reflect its ability to suppress iNOS expression by three distinct mechanisms: decreased stability and translation of iNOS mRNA, and increased degradation of iNOS protein. This is the first evidence that iNOS is subject to other than transcriptional regulation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7688028      PMCID: PMC2191129          DOI: 10.1084/jem.178.2.605

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  42 in total

1.  Induced RAW 264.7 macrophages express soluble and particulate nitric oxide synthase: inhibition by transforming growth factor-beta.

Authors:  U Förstermann; H H Schmidt; K L Kohlhaas; F Murad
Journal:  Eur J Pharmacol       Date:  1992-02-13       Impact factor: 4.432

2.  Purification and characterization of particulate endothelium-derived relaxing factor synthase from cultured and native bovine aortic endothelial cells.

Authors:  J S Pollock; U Förstermann; J A Mitchell; T D Warner; H H Schmidt; M Nakane; F Murad
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

3.  Cytosolic and membrane-bound nitric oxide synthase.

Authors:  K Hiki; Y Yui; R Hattori; H Eizawa; K Kosuga; C Kawai
Journal:  Jpn J Pharmacol       Date:  1991-06

4.  Purification and characterization of the cytokine-induced macrophage nitric oxide synthase: an FAD- and FMN-containing flavoprotein.

Authors:  D J Stuehr; H J Cho; N S Kwon; M F Weise; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1991-09-01       Impact factor: 11.205

5.  Purification of the inducible murine macrophage nitric oxide synthase. Identification as a flavoprotein.

Authors:  J M Hevel; K A White; M A Marletta
Journal:  J Biol Chem       Date:  1991-12-05       Impact factor: 5.157

6.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

7.  Cytokine-activated endothelial cells express an isotype of nitric oxide synthase which is tetrahydrobiopterin-dependent, calmodulin-independent and inhibited by arginine analogs with a rank-order of potency characteristic of activated macrophages.

Authors:  S S Gross; E A Jaffe; R Levi; R G Kilbourn
Journal:  Biochem Biophys Res Commun       Date:  1991-08-15       Impact factor: 3.575

8.  A possible novel pathway of regulation by murine T helper type-2 (Th2) cells of a Th1 cell activity via the modulation of the induction of nitric oxide synthase on macrophages.

Authors:  F Y Liew; Y Li; A Severn; S Millott; J Schmidt; M Salter; S Moncada
Journal:  Eur J Immunol       Date:  1991-10       Impact factor: 5.532

9.  Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide.

Authors:  D J Stuehr; M A Marletta
Journal:  Proc Natl Acad Sci U S A       Date:  1985-11       Impact factor: 11.205

10.  Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line.

Authors:  C R Lyons; G J Orloff; J M Cunningham
Journal:  J Biol Chem       Date:  1992-03-25       Impact factor: 5.157

View more
  151 in total

1.  Blood mononuclear cell nitric oxide production and plasma cytokine levels in healthy gabonese children with prior mild or severe malaria.

Authors:  D J Perkins; P G Kremsner; D Schmid; M A Misukonis; M A Kelly; J B Weinberg
Journal:  Infect Immun       Date:  1999-09       Impact factor: 3.441

2.  Bacterial colonization and the expression of inducible nitric oxide synthase in murine wounds.

Authors:  Eric Mahoney; Jonathan Reichner; Leslie Robinson Bostom; Balduino Mastrofrancesco; William Henry; Jorge Albina
Journal:  Am J Pathol       Date:  2002-12       Impact factor: 4.307

3.  Invasive candidiasis stimulates hepatocyte and monocyte production of active transforming growth factor beta.

Authors:  J J Letterio; T Lehrnbecher; G Pollack; T J Walsh; S J Chanock
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

4.  Immunostimulatory effect of dried bonito extract on mouse macrophage cell lines and mouse primary peritoneal macrophages.

Authors:  Momoko Ishida; Kosuke Nishi; Kozue Shinohara; Nanami Kunihiro; Katsuhiro Osajima; Tomokazu Suemitsu; Takuya Sugahara
Journal:  Cytotechnology       Date:  2017-01-13       Impact factor: 2.058

5.  Persistent Cryptococcus neoformans pulmonary infection in the rat is associated with intracellular parasitism, decreased inducible nitric oxide synthase expression, and altered antibody responsiveness to cryptococcal polysaccharide.

Authors:  D L Goldman; S C Lee; A J Mednick; L Montella; A Casadevall
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

6.  Transgenic expression of TGF-beta on thyrocytes inhibits development of spontaneous autoimmune thyroiditis and increases regulatory T cells in thyroids of NOD.H-2h4 mice.

Authors:  Shiguang Yu; Yujiang Fang; Gordon C Sharp; Helen Braley-Mullen
Journal:  J Immunol       Date:  2010-03-24       Impact factor: 5.422

7.  Tunable Nitric Oxide Release from S-Nitroso-N-acetylpenicillamine via Catalytic Copper Nanoparticles for Biomedical Applications.

Authors:  Jitendra Pant; Marcus J Goudie; Sean P Hopkins; Elizabeth J Brisbois; Hitesh Handa
Journal:  ACS Appl Mater Interfaces       Date:  2017-04-26       Impact factor: 9.229

Review 8.  Cross-talk between nitric oxide and transforming growth factor-beta1 in malaria.

Authors:  Yoram Vodovotz; Ruben Zamora; Matthew J Lieber; Shirley Luckhart
Journal:  Curr Mol Med       Date:  2004-11       Impact factor: 2.222

9.  The mode of action of aspirin-like drugs: effect on inducible nitric oxide synthase.

Authors:  A R Amin; P Vyas; M Attur; J Leszczynska-Piziak; I R Patel; G Weissmann; S B Abramson
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-15       Impact factor: 11.205

10.  Translational control of inducible nitric oxide synthase by p38 MAPK in islet β-cells.

Authors:  Yurika Nishiki; Adeola Adewola; Masayuki Hatanaka; Andrew T Templin; Bernhard Maier; Raghavendra G Mirmira
Journal:  Mol Endocrinol       Date:  2012-12-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.